Search for: "Gray v. Corrections Corp et al" Results 1 - 20 of 23
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
11 Mar 2012, 10:00 am by Zachary Spilman
United States Senate Armed Forces Services Committee, et al., No. 11-1098. [read post]
27 Mar 2007, 6:46 am
[mailto:m.ledford3@ledfordlaw.net] Sent: Tuesday, March 27, 2007 1:11 AMTo: Thomas McCarten Kerr, EsqCc: Barry MerchantSubject: Sony BMG et al. v. [read post]
6 Apr 2010, 4:13 am by Jon L. Gelman
 "Plaintiff presented sufficient evidence to establish that Mark regularly worked in close proximity to asbestos-containing clutches, including those manufactured by Borg-Warner, to permit the issue of causation to go to the jury.Buttitta v Allied Signal, Inc. et al. [read post]
12 Apr 2010, 5:28 am
Mud Buddy, LLC d/b/a Mud Buddy Manufacturing (Docket Report) District Court Utah: Post-motion correction of discovery deficiency warrants sanctions: CleanCut v Rug Doctor et al (Docket Report) District Court C D California answers: May an inventor previously employed by plaintiff’s predecessor-in-interest serve as an expert for defendant? [read post]
27 Mar 2007, 10:09 am
[mailto:m.ledford3@ledfordlaw.net] Sent: Tuesday, March 27, 2007 1:11 AMTo: Thomas McCarten Kerr, EsqCc: Barry MerchantSubject: Sony BMG et al. v. [read post]
  There have also been reports that the FTC is actively investigating violations of past merger consent decrees, potentially with the aim of unwinding the previously cleared merger.15 In this vein, the agencies have been issuing “close at your own risk” letters to merging parties in non-challenged and non-remedy transactions that remind the parties that the agencies retain the authority to challenge mergers after they have closed and that expiration of an HSR waiting period does not… [read post]
9 Jul 2014, 9:34 am by Abbott & Kindermann
Resources Code, § 21000 et seq.) before adopting an ordinance enacting a voter-sponsored initiative pursuant to Elections Code section 9214, subdivision (a)? [read post]
28 Apr 2008, 11:00 am
: (Patent Docs), US: Supreme Court declines to hear final Nucleonics’ appeal in gene-silencing patent dispute with Benitec Australia: (IP Law360), (Therapeutics Daily), US: 505(b)(2) drug approvals rock - Interaction of patents and exclusivity of drugs approved by FDA under section 505(b)(2): (Patent Baristas), US: StemCells’ patents survive reexam – StemCells and Neuralstem differ on extent of changes: (Patent Docs), US: StemCells announces issuance of… [read post]